Universities have long sought partnerships with the pharmaceutical industry to bring new therapies to patients, but often struggle to find investors for early-stage research. Understanding the research landscape within commercial organizations can help academic centers more effectively position research programs in an industry context, and make smarter partnering decisions to advance healthcare and demonstrate an institution’s potential impact on patient lives.
In this webinar recording, our life sciences deal experts dive deeper into partnering activity between academia and pharma to provide insights on:
– Patenting hotspots in the academic drug research landscape.
– Partnering activity in institutions around the globe and what might be driving the differences.
– The timing of deal making between academia and drug companies.
– Best practice approaches for aligning academic research to pharma industry needs for maximum impact.